Synova Life Sciences is a privately-owned biotechnology company that focuses on developing medical devices and methodologies to harvest the body's power to treat symptoms associated with degenerative conditions. Founded in 2013, the company aims to aid physicians and patients by harnessing autologous stem cells and leveraging their regenerative ability to enhance the quality of life.
The company recently received a Seed Round investment on 01 March 2023 from Unpopular Ventures and Titan Angels. This investment demonstrates the attractiveness of the company's vision and technology to potential investors in the venture capital space.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 2 |
|
01 Mar 2023 |
| Seed Round | Unknown | 1 |
|
31 Aug 2021 |
| Seed Round | Unknown | 1 |
|
01 Feb 2021 |
| Seed Round | Unknown | 1 |
|
16 Jul 2020 |
| Pre Seed Round | $150.00K | 1 |
|
18 Mar 2019 |
No recent news or press coverage available for Synova Life Sciences.
We care about your data, and we'd love to use cookies make your experience better.
